↓ Skip to main content

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

Overview of attention for article published in Strahlentherapie und Onkologie, February 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
59 Mendeley
Title
Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study
Published in
Strahlentherapie und Onkologie, February 2019
DOI 10.1007/s00066-019-01434-9
Pubmed ID
Authors

Konrad Kokowski, Stefan Stangl, Sophie Seier, Martin Hildebrandt, Peter Vaupel, Gabriele Multhoff

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Student > Doctoral Student 9 15%
Student > Ph. D. Student 6 10%
Student > Bachelor 5 8%
Other 3 5%
Other 13 22%
Unknown 14 24%
Readers by discipline Count As %
Medicine and Dentistry 20 34%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Nursing and Health Professions 5 8%
Biochemistry, Genetics and Molecular Biology 4 7%
Immunology and Microbiology 3 5%
Other 8 14%
Unknown 14 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2019.
All research outputs
#7,356,230
of 23,923,788 outputs
Outputs from Strahlentherapie und Onkologie
#114
of 777 outputs
Outputs of similar age
#153,572
of 450,827 outputs
Outputs of similar age from Strahlentherapie und Onkologie
#1
of 23 outputs
Altmetric has tracked 23,923,788 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 777 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,827 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.